Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001062993-23-014997

Options or other derivatives

  • Chief Medical Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Macdonald R. Loch Chief Medical Officer 2023-07-14 Grant or award · Stock Options (Right to Buy) +60,000 60,000 D
Loading xslF345X05/form4.xml…